Clinical trial
CAP-Ketamine for Antidepressant Resistant PTSD
NCT02655692 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CAP-Ketamine for Antidepressant Resistant PTSD
- Lead sponsor
- VA Office of Research and Development
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 18, 2016
- Completion date
- July 1, 2020
- Enrollment
- 163 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
posttraumatic stress disorder, ptsd